BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38366178)

  • 1. Drug Nanocrystals: A Delivery Channel for Antiviral Therapies.
    Chaturvedi A; Sharma S; Shukla R
    AAPS PharmSciTech; 2024 Feb; 25(3):41. PubMed ID: 38366178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
    Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
    Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy.
    Megantara S; Rusdin A; Budiman A; Shamsuddin S; Mohtar N; Muchtaridi M
    Int J Nanomedicine; 2024; 19():2889-2915. PubMed ID: 38525012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections.
    Pradhan D; Biswasroy P; Goyal A; Ghosh G; Rath G
    AAPS PharmSciTech; 2021 Jan; 22(1):47. PubMed ID: 33447909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
    Zhou Y; Du J; Wang L; Wang Y
    J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystals: A Deep Insight into Formulation Aspects, Stabilization Strategies, and Biomedical Applications.
    Purohit D; Sharma S; Lamba AK; Saini S; Minocha N; Vashist N; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2023; 17(4):307-326. PubMed ID: 35616680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticles as potential antiviral agents.
    Galdiero S; Falanga A; Vitiello M; Cantisani M; Marra V; Galdiero M
    Molecules; 2011 Oct; 16(10):8894-918. PubMed ID: 22024958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.
    Gao L; Liu G; Ma J; Wang X; Zhou L; Li X; Wang F
    Pharm Res; 2013 Feb; 30(2):307-24. PubMed ID: 23073665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies.
    Ben-Shabat S; Yarmolinsky L; Porat D; Dahan A
    Drug Deliv Transl Res; 2020 Apr; 10(2):354-367. PubMed ID: 31788762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine based approaches for combating viral infections.
    Shah S; Chougule MB; Kotha AK; Kashikar R; Godugu C; Raghuvanshi RS; Singh SB; Srivastava S
    J Control Release; 2021 Oct; 338():80-104. PubMed ID: 34375690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
    Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
    Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.
    Yang KC; Lin JC; Tsai HH; Hsu CY; Shih V; Hu CJ
    Drug Deliv Transl Res; 2021 Aug; 11(4):1420-1437. PubMed ID: 33748879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystal technologies in biomedical science: From the bench to the clinic.
    Pardhi E; Vasave R; Srivastava V; Yadav R; Mehra NK
    Drug Discov Today; 2024 Mar; 29(3):103913. PubMed ID: 38340952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate delivery systems for antiviral drugs.
    Lembo D; Cavalli R
    Antivir Chem Chemother; 2010; 21(2):53-70. PubMed ID: 21107015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art cerium nanoparticles as promising agents against human viral infections.
    Zandi M; Hosseini F; Adli AH; Salmanzadeh S; Behboudi E; Halvaei P; Khosravi A; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113868. PubMed ID: 36257210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
    Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucoadhesive nanocrystal-in-microspheres with high drug loading capacity for bioavailability enhancement of silybin.
    Wang Y; Li H; Wang L; Han J; Yang Y; Fu T; Qiao H; Wang Z; Li J
    Colloids Surf B Biointerfaces; 2021 Feb; 198():111461. PubMed ID: 33246779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.